Advertisement

Topics

White House Mulls Proposal To Pause FDA's Quality Metrics Initiative

17:24 EDT 22 Jun 2017 | SCRIP

Trump administration briefing materials show that the pharmaceutical industry's complaints about FDA's quality metrics initiative are getting high-level attention.

      

Related Stories

 

Original Article: White House Mulls Proposal To Pause FDA's Quality Metrics Initiative

NEXT ARTICLE

More From BioPortfolio on "White House Mulls Proposal To Pause FDA's Quality Metrics Initiative"

Advertisement
Quick Search
Advertisement
Advertisement